Latisse

How does Latisse® work? 

Latisse® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.

Is Latisse® for Everyone?

Latisse® is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients. In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of Latisse® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs for IOP reduction should only use Latisse® after consulting with Dr. Moss and will be monitored for changes to their intraocular pressure.

Are there any potential side effects of Latisse®?

Increased iris pigmentation has occurred when Latisse® solution was administered. There is a potential for increased brown iris pigmentation, which is likely to be permanent. Latisse® has been reported to cause darkened pigmentary changes to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as Latisse® is administered, but has been reported to be reversible upon discontinuation of the medication.

There is a small potential for hair growth to occur in areas where Latisse® solution comes in repeated contact with skin surfaces. There are some other eye conditions (uveitis, aphakia, or known risk factors for macular edema) that are not complete contraindications to use of Latisse® but that Dr. Moss will evaluate on a case by case basis. The most frequently reported adverse reactions were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and periorbital erythema. These reactions occurred in less than 4% of patients.

Instructions for Use  

It is important to use Latisse® solution as instructed, by placing one drop on the single-use-per-eye applicator. The bottle tip should not be allowed to contact any other surface since it could become contaminated. Latisse® contains benzalkonium chloride (BAK), which may be absorbed by soft contact lenses. Contact lenses should be removed prior to application of solution and may be reinserted 15 minutes following its administration.